Do I Qualify?
I have AML. Am I eligible for the SIERRA study?
Find a SIERRA clinical trial site near you
Answers to common questions about SIERRA trial
Targeting Acute Myeloid Leukemia
The SIERRA Trial is investigating the use of Iomab-B in patients age 55 and older with active, relapsed or refractory Acute Myeloid Leukemia (AML)Learn More About SIERRA Trial
What Is It?
Learn More About Iomab-B
Iomab-B is an investigational drug that targets bone marrow and cancer (leukemia) cells. It is used to help patients get ready for bone marrow transplant (BMT)Learn More About Iomab-B